Dystrophin gene transcripts skipping the mdx mutation

Muscle and Nerve

Volumn 20, Issue 6, 1997, Pages 728-734

  Wilton, Stephen D ^a   Dye, Danielle E ^a   Laing, Nigel G ^a  

^a QE Medical Centre   (Australia)

Author keywords

alternate processing; Duchenne muscular dystrophy; dystrophin; exon skipping; revertant fibers

Indexed keywords

DYSTROPHIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DUCHENNE MUSCULAR DYSTROPHY; GENETIC LINKAGE; MOUSE; MUSCLE CELL; NONHUMAN; NONSENSE MUTATION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PROCESSING; PROTEIN SYNTHESIS REGULATION; SARCOLEMMA; TRANSCRIPTION REGULATION;

ANIMALS; BASE SEQUENCE; DISEASE MODELS, ANIMAL; DYSTROPHIN; MICE; MICE, INBRED C57BL; MICE, INBRED MDX; MOLECULAR SEQUENCE DATA; MUTATION; TRANSCRIPTION, GENETIC;

EID: 0030963232     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4598(199706)20:6<728::AID-MUS10>3.0.CO;2-Q     Document Type: Article

References (17)

1. Arahata K, Ishiura S, Ishiguro T, et al. Immunostaining of skeletal and cardiac muscle surface membrane with antibody against Duchenne muscular dystrophy peptide. Nature 1988;333:861-863.
2. Bonilla E, Samitt CE, Miranda AF, Hays AP, Salviati G, DiMauro S, Kunkel LM, Hoffman EP, Rowland LP: Duchenne muscular dystrophy: deficiency of dystrophin at the muscle cell surface. Cell 1988;54:447-452.
3. Bulfield G, Siller WG, Wight PA, Moore KJ: X chromosome-linked muscular dystrophy (mdx) in the mouse. Proc Natl Acad Sci USA 1984;81:1189-1192.
4. Campbell KP, Kahl SD: Association of dystrophin and an integral membrane glycoprotein. Nature 1989;238:259-262.
5. Chamberlain JS, Pearlman JA, Muzny DM, Gibbs RA, Rainer JE, Reeves AA, Caskey CT: Expression of the murine Duchenne muscular dystrophy gene in muscle and brain. Science 1988;239:1416-1418.
6. Chelly J, Kaplan J-C, Maire P, Gautron S, Kahn A: Transcription of the dystrophin gene in human muscle and non-muscle tissues. Nature 1988;333:858-860.
7. Chelly J, Gilgencrantz H, Lambert M, Hanard G, Chafer P, Recan D, Katz P, et al.: Effect of dystrophin deletions on mRNA levels and processing in Duchenne and Becker muscular dystrophies. Cell 1990;63:1239-1248.
8. Cheng S, Fockler C. Barnes WM, Higuchi R: Effective amplification of long targets from cloned inserts and human genomic DNA. Proc Natl Acad Sci USA 1994;91:5695-5699.
9. Clarke P, Lin H, Wilcox G: Ultraviolet imaging: a simple method for detecting nucleic acids in preparative gels. Anal Biochem 1982;124:88-91.
10. Ervasti JM, Campbell KP: Membrane organization of the dystrophin-glycoprotein complex. Cell 1991;108:748-752.
11. Fanin M, Danieli GA, Vitiello L, Senter L, Angelini C: Prevalence of dystrophin positive fibers in 85 Duchenne muscular dystrophy patients. Neuromusc Disord 1992;2:41 - 45.
12. Fanin M. Daniele GA, Cadaldini M, Miorin M, Vitiello L, Angelini C: Dystrophin-positive fibers in Duchenne dystrophy: origin and correlation to clinical course. Muscle Nerve 1995;18:1115-1120.
13. Gangopadhyay SB, Sherratt TG, Heckmatt JZ, Dubowitz V, Miller G, Shokeir M, Ray PN, Strong PN, Worton RG: Dystrophin in frameshit deletion patients with Becker muscular dystrophy. Am J Hum Genet 1992;51:562-570.
14. Gillard EF, Chamberlain JS, Murphy EG, Duff CL, Smith B, Burghes AHM, Thompson MW, et al.: Molecular and phenotypic analysis of patients with deletions within the deletion-rich region of the Duchenne muscular dystrophy (DMD) gene. Am J Hum Genet 1989;45:507-520.
15. Hemmings L, Kuhlman PA, Critchley DR: Analysis of the actin-binding domain of alpha actinin by mutagenesis and demonstration that dystrophin contains a functionally homologous domain. J Cell Biol 1992;116:1369-1380.
16. Hoffman EP, Morgan JE, Watkins SC, Partridge TA: Somatic reversion/suppression of the mouse mdx phenotype in vivo. J Neural Sci 1990;99:9-25.
17. Kaplan J-C, Kahn A, Chelly J: Illegitimate transcription: its use in the study of inherited disease. Hum Mutat 1992;1:357-360.